Author :   Kriachok I.A.

SYSTEMIC MASTOCYTOSIS WITH PRIMARY LESION OF BONE AND LYMPHATIC SYSTEM (LITERATURE REVIEW AND CASE REPORT)

Authors:Zakhartseva L.M. Shatrova K.M. Kriachok I.A. Diatel M.V. ... №17 4 2015 8

STUDY OF POTENTIAL PROGNOSTIC MARKERS IN SMALL LYMPHOCYTIC LYMPHOMA

Authors:Kovalevska L.M. Shlapatska L.M. Aleksyk O.M. Berdova H.H. ... №18 1 2016 6

DEPENDENCE OF EFFICACY AND TOXICITY OF CHEMOTHERAPY IN PATIENTS WITH HODGKIN’S LYMPHOMA OF INTERMEDIATE PROGNOSIS GROUPS ON GSTP1 AND MTHFR GENE POLYMORPHISM

Authors:Kriachok I.A. Amdiev A.A. Titorenko I.B. Kadnikova T.V. ... №18 2 2016 7

HISTORICAL ASPECTS OF NON-HODGKIN’S LYMPHOMA CLASSIFICATION AND UP-TODATE ISSUES OF PROGNOSIS IN DIFFUSE LARGE B-CELL LYMPHOMAS

Authors:Kriachok I.A. Martynchyk A.V. Filonenko K.S. Aleksik O.M. ... №18 3 2016 4

WHETHER С-MYC IS A PROGNOSTIC FACTOR IN PRIMARY MEDIASTINAL (THYMIC) LARGE B-CELL LYMPHOMA?

Authors:Kriachok I.A. Stepanishyna I.A. Grabovoy A.N. Antoniuk S.A. ... №19 1 2017 17

TOPOISOMERASE IIα DETERMINS THE PROGNOSIS AND RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH OPERABLE BREAST CANCER

Authors:Ryspayeva D.E. Kriachok I.A. Smolanka I.I. Dosenko I.V. ... №19 4 2017 13